Equity
Share Repurchase Program - Amount Remaining
Vertex Pharmaceuticals Share Repurchase Program - Amount Remaining decreased by 14.3% to $3.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 211.1%, from $964.40M to $3.00B.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ1 2023
Last reportedQ1 2026May 5, 2026
Metric ID:
share_repurchase_program_amount_remainingHistorical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.90B | $2.80B | $2.70B | $2.40B | $2.10B | $1.80B | $964.40M | $4.60B | $3.50B | $3.00B |
| QoQ Change | — | -3.4% | -3.6% | -11.1% | -12.5% | -14.3% | -46.4% | +377.0% | -23.9% | -14.3% |
| YoY Change | — | — | — | -17.2% | -25.0% | -33.3% | -59.8% | +119.0% | +94.4% | +211.1% |
Range$964.40M – $4.60B
CAGR+1.5%
Avg YoY Growth+41.3%
Median YoY Growth-17.2%
Current Streak2 quarters decline
Share Repurchase Program - Amount Remaining at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's share repurchase program - amount remaining?
- Vertex Pharmaceuticals (VRTX) reported share repurchase program - amount remaining of $3.00B in Q1 2026.
- How has Vertex Pharmaceuticals's share repurchase program - amount remaining changed year-over-year?
- Vertex Pharmaceuticals's share repurchase program - amount remaining increased by 211.1% year-over-year, from $964.40M to $3.00B.